Navigation Links
Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute
Date:12/14/2010

RESEARCH TRIANGLE PARK, N.C., Dec. 14, 2010 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Inc. (Nasdaq: TLCR) announced today that a jury in the General Court of Justice, Superior Court Division, Wake County, North Carolina, rendered a verdict on December 13, 2010 in the amount of $37 million in favor of Plasma Centers of America, LLC, against its subsidiary, Talecris Plasma Resources, Inc., in a breach of contract claim.

Talecris had a three-year Plasma Sale/Purchase Agreement with Plasma Centers of America under which Talecris was required to purchase plasma from plasma collection centers built by Plasma Centers of America and approved by Talecris.  Under the terms of the agreement, Talecris had a conditional obligation to purchase the centers for a sum determined by a formula set forth in the agreement.  Talecris provided approximately $4 million (excluding accrued interest) in financing related to the development of such centers and advanced payments for unlicensed plasma.

In August 2008, Talecris notified Plasma Centers of America that they were in breach of a Plasma Sale/Purchase Agreement.  Talecris terminated the agreement in September 2008.  In November 2008, Talecris filed suit in federal court in Raleigh, North Carolina against the G&M Crandall Limited Family Partnership and its individual partners as guarantors of obligations of Plasma Centers of America.  Plasma Centers of America filed a parallel state action in January 2009, alleging breach of contract by Talecris.

Talecris is evaluating its response to this verdict, including appeal.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and biotechnolog
'/>"/>

SOURCE Talecris Biotherapeutics Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
2. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
3. Talecris Biotherapeutics Announces Premerger HSR Filing
4. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
5. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
6. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
7. Talecris Added to NASDAQ Biotechnology Index
8. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
9. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
10. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
11. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 Virobay, Inc. today announced ... has reached an important milestone, as Virobay has now ... a selective cathepsin S inhibitor.   The ... randomized, placebo-controlled study designed to evaluate the safety, tolerability, ... healthy adults. "The initiation of this Phase ...
(Date:5/23/2013)... , May 23, 2013 Z Trim ... value-added ingredients to a variety of industries, announced that ... a panel discussion at this year,s National Restaurant Association ... 2013, on behalf of the Research Chefs Association.  Chef ... Restaurants: The Good, the Bad and the Ugly," joining ...
(Date:5/23/2013)... EASTON, Mass. , May 23, 2013 ... today announced that the Company will host a teleconference ... to provide a business update. The teleconference information is ... Time: 11:00 a.m. Eastern Daylight Time (EDT) ... ); (302) 607-2001 (Int,l) Passcode: VS22823 ...
(Date:5/23/2013)... BUSAN, South Korea , May 23, 2013 ... collaboration with SillaJen, Inc., a private biotherapeutics and ... of targeted biological products for cancer, announced today ... antibodies in patients treated with the oncolytic and ... This research was published in the ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
... Partner with Biocareercenter.com ... Oct. 2 According to the National,Postdoc Association, more ... the United States today. With only 30 percent of,this ... emerging need to find more quality jobs in the ...
... Calhoun Credits Early Diagnosis with Saving his Life, ... 2007:,The MedTech Conference will highlight how everyday patients are ... as speakers on the,diversity and strength of the economic ... 1 through Oct. 3., Co-writing "A PASSION TO ...
... MISSISSAUGA, ON, Oct. 2 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: ... the research and,commercial development of technologies targeting the ... its,quarterly results after the close of the North ... conference call and audio web cast will also,be ...
Cached Biology Technology:Bio Career Center Launches First Online Jobs Board for Life Science PhDs, MDs 2U.S. Commerce Secretary Gutierrez to Address AdvaMed 2007 2U.S. Commerce Secretary Gutierrez to Address AdvaMed 2007 3Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation 2Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation 3Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation 4
(Date:5/23/2013)... Public Health at Emory University, along with partners ... a $4 million grant over four years to ... and Exposome Research Center: Understanding Lifetime Exposures). The ... in the United States. , The HERCULES ... Environmental Health Sciences (NIEHS) of the National Institutes ...
(Date:5/23/2013)... cancer patients unnecessarily undergo surgery or harsh treatments ... slow-growing and aggressive forms of the disease. Researchers ... Medical Institutes are developing technology that allows patients ... relatively mild treatments or take drastic measures. , ... an associate professor of biomedical engineering at Case ...
(Date:5/23/2013)... of the world,s largest and fastest growing open-access ... Frontiers in Bioengineering and Biotechnology . ... Frontiers in Bioengineering and Biotechnology will ... emerging bioengineering and biotechnology research to be disseminated ... and Biotechnology will provide an open-science and ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3Frontiers launches new open-access journal in Bioengineering and Biotechnology 2
... the Americas avoid competing for the same lunch, or ... from a new study by a pair of researchers ... shows that it,s not just chance that,s at play, ... force in the evolution of many carnivores, influencing such ...
... 10, 2009)The use of common and readily available screening ... scoring systemssuch as the Framingham Risk Scorehas the potential ... who are not originally thought to be at high ... Society of Interventional Radiology,s 34th Annual Scientific Meeting. About ...
... but scientists have found a Yellowstone National Park alga ... algae called Cyanidioschyzon -- thrives in extremely ... around hot springs, said Tim McDermott, professor in the ... State University. Cyanidioschyzon could someday help ...
Cached Biology News:American carnivores evolved to avoid each other, new study suggests 2Simple test helps predict heart attack risk 2Simple test helps predict heart attack risk 3Montana State team finds Yellowstone alga that detoxifies arsenic 2Montana State team finds Yellowstone alga that detoxifies arsenic 3
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
Normal Bovine Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin lev...
...
Biology Products: